TickerFacts.

Relmada Therapeutics, Inc. (RLMD): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2013-08-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$5.1K
Year ended 2013-08-31
$7.9K2012-08-31: $7.9K2013-08-31: $5.1K$5.1K
2012-08-31 Revenue (USD) 2013-08-31
Period endedRevenueChange YoYSource filing
2013-08-31$5.1K-35.4%2013-12-16, From 2012-09-01
2012-08-31$7.9Kn/a2013-12-16, From 2011-09-01